Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ARE vs AMGN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ARE
Alexandria Real Estate Equities, Inc.

REIT - Office

Real EstateNYSE • US
Market Cap$7.93B
5Y Perf.-70.2%
AMGN
Amgen Inc.

Drug Manufacturers - General

HealthcareNASDAQ • US
Market Cap$178.70B
5Y Perf.+44.1%

ARE vs AMGN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ARE logoARE
AMGN logoAMGN
IndustryREIT - OfficeDrug Manufacturers - General
Market Cap$7.93B$178.70B
Revenue (TTM)$2.90B$37.24B
Net Income (TTM)$-1.02B$7.80B
Gross Margin68.2%71.5%
Operating Margin-42.8%31.6%
Forward P/E79.2x14.8x
Total Debt$12.76B$54.60B
Cash & Equiv.$549M$9.13B

ARE vs AMGNLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ARE
AMGN
StockMay 20May 26Return
Alexandria Real Est… (ARE)10029.8-70.2%
Amgen Inc. (AMGN)100144.1+44.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: ARE vs AMGN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AMGN leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Alexandria Real Estate Equities, Inc. is the stronger pick specifically for dividend income and shareholder returns. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ARE
Alexandria Real Estate Equities, Inc.
The Real Estate Income Play

ARE is the clearest fit if your priority is income & stability.

  • Dividend streak 15 yrs, beta 0.95, yield 11.7%
  • 11.7% yield, 15-year raise streak, vs AMGN's 2.9%
Best for: income & stability
AMGN
Amgen Inc.
The Growth Play

AMGN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 9.9%, EPS growth 88.2%, 3Y rev CAGR 11.8%
  • 161.5% 10Y total return vs ARE's -7.5%
  • Lower volatility, beta 0.60, current ratio 1.14x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthAMGN logoAMGN9.9% revenue growth vs ARE's -2.6%
ValueAMGN logoAMGNLower P/E (14.8x vs 79.2x)
Quality / MarginsAMGN logoAMGN20.9% margin vs ARE's -35.3%
Stability / SafetyAMGN logoAMGNBeta 0.60 vs ARE's 0.95
DividendsARE logoARE11.7% yield, 15-year raise streak, vs AMGN's 2.9%
Momentum (1Y)AMGN logoAMGN+26.0% vs ARE's -30.3%
Efficiency (ROA)AMGN logoAMGN8.6% ROA vs ARE's -2.9%, ROIC 14.8% vs -2.7%

ARE vs AMGN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AREAlexandria Real Estate Equities, Inc.
FY 2025
Rental revenues
97.3%$2.9B
Product and Service, Other
2.7%$81M
AMGNAmgen Inc.
FY 2025
Other Products
20.6%$7.3B
Prolia
12.5%$4.4B
Repatha
8.5%$3.0B
Otezla
6.4%$2.3B
ENBREL
6.3%$2.2B
EVENITY
5.9%$2.1B
XGEVA
5.9%$2.1B
Other (8)
33.9%$12.0B

ARE vs AMGN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAMGNLAGGINGARE

Income & Cash Flow (Last 12 Months)

AMGN leads this category, winning 4 of 6 comparable metrics.

AMGN is the larger business by revenue, generating $37.2B annually — 12.8x ARE's $2.9B. AMGN is the more profitable business, keeping 20.9% of every revenue dollar as net income compared to ARE's -35.3%. On growth, AMGN holds the edge at +5.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricARE logoAREAlexandria Real E…AMGN logoAMGNAmgen Inc.
RevenueTrailing 12 months$2.9B$37.2B
EBITDAEarnings before interest/tax$74M$15.6B
Net IncomeAfter-tax profit-$1.0B$7.8B
Free Cash FlowCash after capex$1.4B$8.6B
Gross MarginGross profit ÷ Revenue+68.2%+71.5%
Operating MarginEBIT ÷ Revenue-42.8%+31.6%
Net MarginNet income ÷ Revenue-35.3%+20.9%
FCF MarginFCF ÷ Revenue+48.4%+23.1%
Rev. Growth (YoY)Latest quarter vs prior year-9.7%+5.8%
EPS Growth (YoY)Latest quarter vs prior year+31.9%+4.4%
AMGN leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ARE leads this category, winning 4 of 6 comparable metrics.

On an enterprise value basis, AMGN's 14.1x EV/EBITDA is more attractive than ARE's 135.9x.

MetricARE logoAREAlexandria Real E…AMGN logoAMGNAmgen Inc.
Market CapShares × price$7.9B$178.7B
Enterprise ValueMkt cap + debt − cash$20.1B$224.2B
Trailing P/EPrice ÷ TTM EPS-5.43x23.27x
Forward P/EPrice ÷ next-FY EPS est.79.22x14.83x
PEG RatioP/E ÷ EPS growth rate7.91x
EV / EBITDAEnterprise value multiple135.94x14.15x
Price / SalesMarket cap ÷ Revenue2.67x4.86x
Price / BookPrice ÷ Book value/share0.41x20.73x
Price / FCFMarket cap ÷ FCF5.61x22.06x
ARE leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

AMGN leads this category, winning 6 of 9 comparable metrics.

AMGN delivers a 89.4% return on equity — every $100 of shareholder capital generates $89 in annual profit, vs $-5 for ARE. ARE carries lower financial leverage with a 0.67x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMGN's 6.31x. On the Piotroski fundamental quality scale (0–9), AMGN scores 7/9 vs ARE's 5/9, reflecting strong financial health.

MetricARE logoAREAlexandria Real E…AMGN logoAMGNAmgen Inc.
ROE (TTM)Return on equity-5.0%+89.4%
ROA (TTM)Return on assets-2.9%+8.6%
ROICReturn on invested capital-2.7%+14.8%
ROCEReturn on capital employed-3.6%+16.0%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.67x6.31x
Net DebtTotal debt minus cash$12.2B$45.5B
Cash & Equiv.Liquid assets$549M$9.1B
Total DebtShort + long-term debt$12.8B$54.6B
Interest CoverageEBIT ÷ Interest expense-4.37x5.02x
AMGN leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AMGN leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in AMGN five years ago would be worth $14,871 today (with dividends reinvested), compared to $3,937 for ARE. Over the past 12 months, AMGN leads with a +26.0% total return vs ARE's -30.3%. The 3-year compound annual growth rate (CAGR) favors AMGN at 15.2% vs ARE's -21.1% — a key indicator of consistent wealth creation.

MetricARE logoAREAlexandria Real E…AMGN logoAMGNAmgen Inc.
YTD ReturnYear-to-date-4.9%+1.8%
1-Year ReturnPast 12 months-30.3%+26.0%
3-Year ReturnCumulative with dividends-50.8%+52.8%
5-Year ReturnCumulative with dividends-60.6%+48.7%
10-Year ReturnCumulative with dividends-7.5%+161.5%
CAGR (3Y)Annualised 3-year return-21.1%+15.2%
AMGN leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

AMGN leads this category, winning 2 of 2 comparable metrics.

AMGN is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than ARE's 0.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMGN currently trades 84.6% from its 52-week high vs ARE's 51.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricARE logoAREAlexandria Real E…AMGN logoAMGNAmgen Inc.
Beta (5Y)Sensitivity to S&P 5000.95x0.60x
52-Week HighHighest price in past year$88.24$391.29
52-Week LowLowest price in past year$39.41$261.43
% of 52W HighCurrent price vs 52-week peak+51.9%+84.6%
RSI (14)Momentum oscillator 0–10046.137.9
Avg Volume (50D)Average daily shares traded2.4M2.5M
AMGN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

ARE leads this category, winning 1 of 1 comparable metric.

Wall Street rates ARE as "Hold" and AMGN as "Buy". Consensus price targets imply 20.0% upside for ARE (target: $55) vs 5.9% for AMGN (target: $351). For income investors, ARE offers the higher dividend yield at 11.67% vs AMGN's 2.86%.

MetricARE logoAREAlexandria Real E…AMGN logoAMGNAmgen Inc.
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$55.00$350.76
# AnalystsCovering analysts2438
Dividend YieldAnnual dividend ÷ price+11.7%+2.9%
Dividend StreakConsecutive years of raises1515
Dividend / ShareAnnual DPS$5.35$9.45
Buyback YieldShare repurchases ÷ mkt cap+2.6%0.0%
ARE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

AMGN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARE leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallAmgen Inc. (AMGN)Leads 4 of 6 categories
Loading custom metrics...

ARE vs AMGN: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ARE or AMGN a better buy right now?

For growth investors, Amgen Inc.

(AMGN) is the stronger pick with 9. 9% revenue growth year-over-year, versus -2. 6% for Alexandria Real Estate Equities, Inc. (ARE). Amgen Inc. (AMGN) offers the better valuation at 23. 3x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate Amgen Inc. (AMGN) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ARE or AMGN?

On forward P/E, Amgen Inc.

is actually cheaper at 14. 8x.

03

Which is the better long-term investment — ARE or AMGN?

Over the past 5 years, Amgen Inc.

(AMGN) delivered a total return of +48. 7%, compared to -60. 6% for Alexandria Real Estate Equities, Inc. (ARE). Over 10 years, the gap is even starker: AMGN returned +161. 5% versus ARE's -7. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ARE or AMGN?

By beta (market sensitivity over 5 years), Amgen Inc.

(AMGN) is the lower-risk stock at 0. 60β versus Alexandria Real Estate Equities, Inc. 's 0. 95β — meaning ARE is approximately 58% more volatile than AMGN relative to the S&P 500. On balance sheet safety, Alexandria Real Estate Equities, Inc. (ARE) carries a lower debt/equity ratio of 67% versus 6% for Amgen Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ARE or AMGN?

By revenue growth (latest reported year), Amgen Inc.

(AMGN) is pulling ahead at 9. 9% versus -2. 6% for Alexandria Real Estate Equities, Inc. (ARE). On earnings-per-share growth, the picture is similar: Amgen Inc. grew EPS 88. 2% year-over-year, compared to -568. 9% for Alexandria Real Estate Equities, Inc.. Over a 3-year CAGR, AMGN leads at 11. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ARE or AMGN?

Amgen Inc.

(AMGN) is the more profitable company, earning 21. 0% net margin versus -48. 2% for Alexandria Real Estate Equities, Inc. — meaning it keeps 21. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMGN leads at 29. 1% versus -40. 5% for ARE. At the gross margin level — before operating expenses — AMGN leads at 70. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ARE or AMGN more undervalued right now?

On forward earnings alone, Amgen Inc.

(AMGN) trades at 14. 8x forward P/E versus 79. 2x for Alexandria Real Estate Equities, Inc. — 64. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARE: 20. 0% to $55. 00.

08

Which pays a better dividend — ARE or AMGN?

All stocks in this comparison pay dividends.

Alexandria Real Estate Equities, Inc. (ARE) offers the highest yield at 11. 7%, versus 2. 9% for Amgen Inc. (AMGN).

09

Is ARE or AMGN better for a retirement portfolio?

For long-horizon retirement investors, Amgen Inc.

(AMGN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60), 2. 9% yield, +161. 5% 10Y return). Both have compounded well over 10 years (AMGN: +161. 5%, ARE: -7. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ARE and AMGN?

These companies operate in different sectors (ARE (Real Estate) and AMGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ARE is a small-cap income-oriented stock; AMGN is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ARE

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Gross Margin > 40%
  • Dividend Yield > 4.6%
Run This Screen
Stocks Like

AMGN

Dividend Mega-Cap Quality

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ARE and AMGN on the metrics below

Revenue Growth>
%
(ARE: -9.7% · AMGN: 5.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.